Molecular mechanisms involved in the antiproliferative effect of two COX-2 inhibitors, nimesulide and NS-398, on colorectal cancer cell lines

Dubois, 1998, Cyclooxygenase in biology and disease, FASEB J, 12, 1063, 10.1096/fasebj.12.12.1063 Smith, 2001, Why there are two cyclooxygenase isozymes, J Clin Invest, 107, 1491, 10.1172/JCI13271 Williams, 1996, Prostaglandin endoperoxide synthase: why two isoforms?, Am J Physiol, 270, G393 Shao, 1999, Coordinate regulation of cyclooxygenase-2 and TGF-beta1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors, Carcinogenesis, 20, 185, 10.1093/carcin/20.2.185 Boolbol, 1996, Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis, Cancer Res, 56, 2556 Eberhart, 1994, Up-regulation of cyclooxygenase gene expression in human colorectal adenomas and adenocarcinomas, Gastroenterology, 107, 1183, 10.1016/0016-5085(94)90246-1 Sano, 1995, Expression of cyclooxygenase-1 and -2 in human colorectal cancer, Cancer Res, 55, 3785 Kargman, 1995, Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer, Cancer Res, 55, 2556 Kutchera, 1996, Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect, Proc Natl Acad Sci USA, 93, 4816, 10.1073/pnas.93.10.4816 Chapple, 2002, Analysis of cyclooxygenase expression in human colorectal adenomas, Dis Colon Rectum, 45, 1316, 10.1007/s10350-004-6418-3 Hasegawa, 2001, Expression of cyclooxygenase-2 (COX-2) mRNA in human colorectal adenomas, Eur J Cancer, 37, 1469, 10.1016/S0959-8049(01)00137-X Rigas, 1993, Altered eicosanoid levels in human colon cancer, J Lab Clin Med, 122, 518 Tsujii, 1995, Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2, Cell, 83, 493, 10.1016/0092-8674(95)90127-2 Buecher, 2001, Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer, Gastroenterol Clin Biol, 25, 967 Paganini-Hill, 1992, Aspirin use and reduced risk of fatal colon cancer, N Engl J Med, 326, 1290 Thun, 1993, Aspirin use and risk of fatal cancer, Cancer Res, 53, 1322 Giovannucci, 1994, Aspirin use and the risk for colorectal cancer and adenoma in male health professionals, Ann Intern Med, 121, 241, 10.7326/0003-4819-121-4-199408150-00001 Giovannucci, 1995, Aspirin and the risk of colorectal cancer in women, N Engl J Med, 333, 609, 10.1056/NEJM199509073331001 Smalley, 1999, Use of non-steroidal anti-inflammatory drugs and incidence of colorectal cancer. A population-based study, Arch Intern Med, 159, 161, 10.1001/archinte.159.2.161 Garcia Rodriguez, 2001, Reduced risk of colorectal cancer among long-term users of aspirin and non-aspirin non-steroidal antiinflammatory drugs, Epidemiology, 12, 88, 10.1097/00001648-200101000-00015 Breuer-Katschinski, 2000, The colorectal adenoma study group. Long-term use of non-steroidal antiinflammatory drugs and the risk of colorectal adenomas, Digestion, 61, 129, 10.1159/000007745 Thun, 2002, Non-steroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues, J Natl Cancer Inst, 94, 252, 10.1093/jnci/94.4.252 Sandler, 2003, A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer, N Engl J Med, 348, 883, 10.1056/NEJMoa021633 Baron, 2003, A randomized trial of aspirin to prevent colorectal adenomas, N Engl J Med, 348, 891, 10.1056/NEJMoa021735 Labayle, 1991, Sulindac causes regression of rectal polyps in familial adenomatous polyposis, Gastroenterology, 101, 635, 10.1016/0016-5085(91)90519-Q Giardiello, 1993, Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis, N Engl J Med, 328, 1313, 10.1056/NEJM199305063281805 Nugent, 1993, Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis, Br J Surg, 80, 1618, 10.1002/bjs.1800801244 Cruz-Correa, 2002, Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study, Gastroenterology, 122, 641, 10.1053/gast.2002.31890 Steinbach, 2000, The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis, N Engl J Med, 342, 1946, 10.1056/NEJM200006293422603 Wolfe, 1999, Gastrointestinal toxicity of non-steroidal antiinflammatory drugs, N Engl J Med, 340, 1888, 10.1056/NEJM199906173402407 De Leval, 2000, Recent advances in inducible cyclooxygenase (COX-2) inhibition, Curr Med Chem, 7, 1041, 10.2174/0929867310007011041 Famaey, 1997, In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview, Inflamm Res, 46, 437, 10.1007/s000110050221 Wober, 1999, Comparative efficacy and safety of nimesulide and diclofenac in patients with acute shoulder, and a metanalysis of controlled studies with nimesulide, Rheumatology (Oxford), 38, 33, 10.1093/rheumatology/38.suppl_1.33 Shiff, 1995, Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells, J Clin Invest, 96, 491, 10.1172/JCI118060 Piazza, 1995, Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis, Cancer Res, 55, 3110 Goldberg, 1996, The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins, Oncogene, 12, 893 Ricchi, 1997, Effect of aspirin on cell proliferation and differentiation of colon adenocarcinoma Caco-2 cells, Int J Cancer, 73, 880, 10.1002/(SICI)1097-0215(19971210)73:6<880::AID-IJC20>3.0.CO;2-7 Elder, 1997, Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective non-steroidal anti-inflammatory drug: independence from COX-2 protein expression, Clin Cancer Res, 3, 1679 Smith, 2000, The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action, Eur J Cancer, 36, 664, 10.1016/S0959-8049(99)00333-0 Elder, 2000, Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398, Int J Cancer, 86, 553, 10.1002/(SICI)1097-0215(20000515)86:4<553::AID-IJC18>3.0.CO;2-9 Grösch, 2001, COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib, FASEB J, 15, 2742, 10.1096/fj.01-0299fje Yang, 2001, p21(WAF1/cip1) is an important determinant of intestinal cell response to sulindac in vitro and in vivo, Cancer Res, 61, 6297 Yamazaki, 2002, Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells, FEBS Lett, 531, 278, 10.1016/S0014-5793(02)03535-4 Sherr, 1996, Cancer cell cycles, Science, 274, 1672, 10.1126/science.274.5293.1672 Xiong, 1996, Why are there so many CDK inhibitors?, Biochim Biophys Acta, 1288, 1 Chin, 1998, The INK4a/ARF tumor suppressor: one gene—two products—two pathways, Trends Biochem Sci, 23, 291, 10.1016/S0968-0004(98)01236-5 Lundberg, 1999, Control of the cell cycle and apoptosis, Eur J Cancer, 35, 531, 10.1016/S0959-8049(99)00292-0 Weinberg, 1995, The retinoblastoma protein and cell cycle control, Cell, 81, 323, 10.1016/0092-8674(95)90385-2 Siavoshian, 2000, Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression, Gut, 46, 507, 10.1136/gut.46.4.507 Kishimoto, 2002, Effects of cyclooxygenase-2 inhibitor NS-398 on APC and c-myc expression in rat colon carcinogenesis induced by azoxymethane, J Gastroenterol, 37, 186, 10.1007/s005350200019 Fukutake, 1998, Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice, Carcinogenesis, 19, 1939, 10.1093/carcin/19.11.1939 Liu, 1998, NS-398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells, Cancer Res, 58, 4245 Molina, 1999, Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by non-steroidal anti-inflammatory drugs, Cancer Res, 59, 4356 Hung, 2000, Induction of p27(KIP1) as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells, Mol Pharmacol, 58, 1398, 10.1124/mol.58.6.1398 Li, 2001, Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS-398 through a cytochrome C-dependent pathway in esophageal cancer cells, Int J Cancer, 15, 218, 10.1002/ijc.1322 Cheng, 2002, NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines, Int J Cancer, 99, 755, 10.1002/ijc.10409 Toyoshima, 2002, Inhibitor of cyclooxygenase-2 induces cell-cycle arrest in the epithelial cancer cell line via up-regulation of cyclin dependent kinase inhibitor p21, Br J Cancer, 86, 1150, 10.1038/sj.bjc.6600183 Kralj, 2001, Effect of the non-steroidal anti-inflammatory drug indomethacin on proliferation and apoptosis of colon carcinoma cells, J Cancer Res Clin Oncol, 127, 173, 10.1007/s004320000196 Marra, 2000, Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21Waf1 and p27Kip1, Circulation, 102, 2124, 10.1161/01.CIR.102.17.2124 Huang, 2002, Mechanisms underlying non-steroidal anti-inflammatory drug-induced p27Kip1 expression, Mol Pharmacol, 62, 1515, 10.1124/mol.62.6.1515 Tegeder, 2001, Cyclooxygenase-independent actions of cyclooxygenase inhibitors, FASEB J, 15, 2057, 10.1096/fj.01-0390rev Hsi, 2000, Lack of cyclooxygenase activity in HT-29 human colorectal carcinoma cells, Exp Cell Res, 256, 563, 10.1006/excr.2000.4863 Warner, 1999, Non-steroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis, Proc Natl Acad Sci USA, 96, 7563, 10.1073/pnas.96.13.7563